Medpace Holdings, Inc. is 1.5x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($13.30 B vs $8.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MEDP | CRL |
|---|---|---|
| Market cap | $13.30 B | $8.97 B |
| US-listed rank | #785 | #1006 |
| Revenue (latest FY) | $2.53B | $4.02B |
| Net income (latest FY) | $451.12M | -$144.34M |
| Net margin | 17.8% | -3.6% |
| P/E (trailing FY) | 29.5 | - |
| SEC filings | 874 | 2,387 |
Medpace Holdings, Inc. is 1.5x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($13.30 B vs $8.97 B).
In their latest fiscal years, Medpace Holdings, Inc. reported $2.53B in revenue while CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported $4.02B.
Full pages: Medpace Holdings, Inc. and CHARLES RIVER LABORATORIES INTERNATIONAL, INC., or browse the full rankings.